Cargando…

Atrial fibrillation in patients with ischemic stroke: A population-based study

BACKGROUND: Atrial fibrillation is a major risk factor for ischemic stroke. However, the prognostic impact of atrial fibrillation among patients with stroke is not fully clarified. We compared patient characteristics, including severity of stroke and comorbidity, quality of in-hospital care and outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Thygesen, Sandra Kruchov, Frost, Lars, Eagle, Kim A, Johnsen, Søren Paaske
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943164/
https://www.ncbi.nlm.nih.gov/pubmed/20865087
_version_ 1782187002803781632
author Thygesen, Sandra Kruchov
Frost, Lars
Eagle, Kim A
Johnsen, Søren Paaske
author_facet Thygesen, Sandra Kruchov
Frost, Lars
Eagle, Kim A
Johnsen, Søren Paaske
author_sort Thygesen, Sandra Kruchov
collection PubMed
description BACKGROUND: Atrial fibrillation is a major risk factor for ischemic stroke. However, the prognostic impact of atrial fibrillation among patients with stroke is not fully clarified. We compared patient characteristics, including severity of stroke and comorbidity, quality of in-hospital care and outcomes in a cohort of first-time ischemic stroke patients with and without atrial fibrillation. METHODS: Based on linkage of public medical databases, we did a population-based follow-up study among 3,849 stroke patients from the County of Aarhus, Denmark admitted in the period of 2003–2007 and prospectively registered in the Danish National Indicator Project. RESULTS: Atrial fibrillation was associated with an adverse prognostic profile but not with an overall poorer quality of in-hospital care. Patients with atrial fibrillation had a longer total length of stay (median: 15 vs 9 days), and were at increased risk of in-hospital medical complications (adjusted relative risk = 1.48, 95% CI: 1.23–1.79) and recurrent stroke (adjusted hazard ratio = 1.30, 95% CI: 0.93–1.82) when compared with patients without atrial fibrillation. The adjusted hazard ratios for 30 days and one year mortality were 1.55 (95% CI: 1.20–2.01) and 1.55 (95% CI: 1.30–1.85), respectively. Patients not eligible to oral anticoagulant treatment had an increased risk of recurrent stroke (adjusted hazard ratio = 1.92, 95% CI: 1.19–3.11). CONCLUSION: Atrial fibrillation is associated with a poor outcome among patients with ischemic stroke particularly among patients, who are not eligible to oral anticoagulant treatment.
format Text
id pubmed-2943164
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-29431642010-09-23 Atrial fibrillation in patients with ischemic stroke: A population-based study Thygesen, Sandra Kruchov Frost, Lars Eagle, Kim A Johnsen, Søren Paaske Clin Epidemiol Original Research BACKGROUND: Atrial fibrillation is a major risk factor for ischemic stroke. However, the prognostic impact of atrial fibrillation among patients with stroke is not fully clarified. We compared patient characteristics, including severity of stroke and comorbidity, quality of in-hospital care and outcomes in a cohort of first-time ischemic stroke patients with and without atrial fibrillation. METHODS: Based on linkage of public medical databases, we did a population-based follow-up study among 3,849 stroke patients from the County of Aarhus, Denmark admitted in the period of 2003–2007 and prospectively registered in the Danish National Indicator Project. RESULTS: Atrial fibrillation was associated with an adverse prognostic profile but not with an overall poorer quality of in-hospital care. Patients with atrial fibrillation had a longer total length of stay (median: 15 vs 9 days), and were at increased risk of in-hospital medical complications (adjusted relative risk = 1.48, 95% CI: 1.23–1.79) and recurrent stroke (adjusted hazard ratio = 1.30, 95% CI: 0.93–1.82) when compared with patients without atrial fibrillation. The adjusted hazard ratios for 30 days and one year mortality were 1.55 (95% CI: 1.20–2.01) and 1.55 (95% CI: 1.30–1.85), respectively. Patients not eligible to oral anticoagulant treatment had an increased risk of recurrent stroke (adjusted hazard ratio = 1.92, 95% CI: 1.19–3.11). CONCLUSION: Atrial fibrillation is associated with a poor outcome among patients with ischemic stroke particularly among patients, who are not eligible to oral anticoagulant treatment. Dove Medical Press 2009-08-09 /pmc/articles/PMC2943164/ /pubmed/20865087 Text en © 2009 Thygesen et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Thygesen, Sandra Kruchov
Frost, Lars
Eagle, Kim A
Johnsen, Søren Paaske
Atrial fibrillation in patients with ischemic stroke: A population-based study
title Atrial fibrillation in patients with ischemic stroke: A population-based study
title_full Atrial fibrillation in patients with ischemic stroke: A population-based study
title_fullStr Atrial fibrillation in patients with ischemic stroke: A population-based study
title_full_unstemmed Atrial fibrillation in patients with ischemic stroke: A population-based study
title_short Atrial fibrillation in patients with ischemic stroke: A population-based study
title_sort atrial fibrillation in patients with ischemic stroke: a population-based study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943164/
https://www.ncbi.nlm.nih.gov/pubmed/20865087
work_keys_str_mv AT thygesensandrakruchov atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy
AT frostlars atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy
AT eaglekima atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy
AT johnsensørenpaaske atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy